Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,471.00    11.00 (0.75%)
Bid:
1,475.00
Ask:
1,477.00
Spread: 2.00 (0.136%)
Market Cap: £3.13b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Option Exercise

19 Sep 2007 16:22

Hikma Pharmaceuticals Plc19 September 2007 For Immediate Release 19 September 2007 Hikma Pharmaceuticals PLC (the "Company") Director/PDMR Shareholding Notification of Option Exercise On 19 September 2007 the following PDMRs exercised their option to purchase thenumber of ordinary shares of 10 pence each set out in the table below in thecapital of the Company. These options were granted on the dates shown belowpursuant to the Company's 2004 Stock Option Plan: +--------------------+---------------+-------------------------------------+|Name |Date of Grant |Number of Shares Exercised |+--------------------+---------------+-------------------------------------+|Majda Labadi |12 October 2004|120,000 |+--------------------+---------------+-------------------------------------+|Taghreed Al Shunnar |12 October 2004|120,000 |+--------------------+---------------+-------------------------------------+ On 19 September 2007, the PDMRs disposed of the following number of shares acquired pursuant to the exercise of the options set out above: +-------------------+-----------------+------------------------+-------------------------+---------------------------+|Name |Date of Disposal |Market Price on Disposal|Number of Shares Disposed|Percentage of Share capital|| | | | | |+-------------------+-----------------+------------------------+-------------------------+---------------------------+|Majda Labadi |19 September 2007|£4.210201 |120,000 |0.0708% |+-------------------+-----------------+------------------------+-------------------------+---------------------------+|Taghreed Al Shunnar|19 September 2007|£4.210201 |120,000 |0.0708% |+-------------------+-----------------+------------------------+-------------------------+---------------------------+ As a result of the above transactions the Executive Directors and PDMRs listedbelow now have the following holdings in the ordinary share capital of theCompany: +-------------------+------------------------------+---------------------------+|Name |Ordinary Shares in the Company|Percentage of Share capital|| | | |+-------------------+------------------------------+---------------------------+|Majda Labadi |305,740 |0.1804% |+-------------------+------------------------------+---------------------------+|Taghreed Al Shunnar|29,640 |0.0175% |+-------------------+------------------------------+---------------------------+ The issued share capital of Hikma Pharmaceuticals PLC is now 169,435,407 ordinary shares of 10 pence each. Date of Notification: 19 September 2007 Henry KnowlesCompany Secretary020 7399 2760 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Mar 20214:44 pmRNSDirector/PDMR Shareholding
25th Feb 20211:02 pmRNSDirector/PDMR Shareholding
25th Feb 20211:02 pmRNSDirector/PDMR Shareholding
25th Feb 20211:01 pmRNSDirector/PDMR Shareholding
25th Feb 20211:00 pmRNSDirector/PDMR Shareholding
25th Feb 20217:00 amRNSFinal Results
8th Feb 20212:55 pmRNSNotice of Results
26th Jan 20218:01 amRNSPotential Acquisition
15th Jan 20213:59 pmRNSHikma provides update on generic Advair Diskus®
13th Jan 20219:21 amRNSDirector/PDMR Shareholding
13th Jan 20219:14 amRNSDirector/PDMR Shareholding
18th Dec 202010:10 amRNSHolding(s) in Company
17th Dec 20205:30 pmRNSHikma launches generic Advair Diskus®
14th Dec 202012:57 pmRNSHolding(s) in Company
10th Dec 20204:00 pmRNSDirector/PDMR Shareholding
10th Dec 20203:51 pmRNSDirector/PDMR Shareholding
2nd Dec 20203:00 pmRNSTotal Voting Rights
2nd Dec 20201:05 pmRNSHolding(s) in Company
9th Nov 202011:38 amRNSHolding(s) in Company
5th Nov 202011:30 amRNSDirectorate Change
5th Nov 20207:00 amRNSHikma launches Icosapent Ethyl Capsules
5th Nov 20207:00 amRNSTrading Statement
2nd Nov 20201:20 pmRNSTotal Voting Rights
22nd Oct 20201:16 pmRNSNotice to Bondholders
8th Oct 20208:38 amRNSBlocklisting Application
1st Oct 202011:01 amRNSBlock listing Interim Review
22nd Sep 20207:00 amRNSHikma updates on ANDA for generic Advair Diskus®
3rd Sep 20203:15 pmRNSHikma receives favourable court ruling
2nd Sep 20209:30 amRNSTotal Voting Rights
7th Aug 20207:00 amRNSHalf-year Report
3rd Aug 20202:25 pmRNSTotal Voting Rights
16th Jul 202012:06 pmRNSNotice of Results
7th Jul 202012:48 pmRNSPublication of Offering Circular
25th Jun 20204:12 pmRNSHolding(s) in Company
25th Jun 20201:00 pmRNSDirectorate Change
23rd Jun 20205:30 pmRNSHikma Pharmaceuticals
23rd Jun 202011:39 amRNSHolding(s) in Company
23rd Jun 20207:00 amRNSTransaction in Own Shares
23rd Jun 20207:00 amRNSResult of placing in Hikma Pharmaceuticals PLC
22nd Jun 20205:13 pmRNSTransaction in Own Shares
22nd Jun 20205:09 pmRNSProposed Placing in Hikma Pharmaceuticals PLC
22nd Jun 202011:24 amRNSDirector/PDMR Shareholding
22nd Jun 202011:22 amRNSDirector/PDMR Shareholding
22nd Jun 202011:20 amRNSDirector/PDMR Shareholding
2nd Jun 20209:31 amRNSTotal Voting Rights
22nd May 20207:00 amRNSHikma receives FDA approval for generic Vascepa®
20th May 20203:42 pmRNSDirector/PDMR Shareholding
13th May 20201:28 pmRNSDirector/PDMR Shareholding
1st May 202011:30 amRNSTotal Voting Rights
30th Apr 202012:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.